ORIGINALE: Fewer Cases of New Diabetes With InsulinORIGINALE: Fewer Cases of New Diabetes With Insulin

The 2.5-year follow-on study from the ORIGIN trial confirms the neutral effect of insulin glargine on CV events and cancer, while indicating that insulin may be able to reduce development of new diabetes. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news